ATB 346
Products
Description
ATB 346, a novel hydrogen sulphide-releasing derivative of naproxen with remarkably reduced toxicity, inhibits COX activity. ATB 346 is an anti-inflammatory agent that induces apoptosis of human melanoma cells.
Specifications
| Manufacturer Cat# | S6615 |
|---|---|
| Target | COX |